Could a benign breast biopsy predict cancer? new study seeks answers

NCT ID NCT07207564

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This Mayo Clinic study is recruiting 4,500 women who had a benign breast biopsy between 2002 and 2022. Researchers will examine tissue samples, mammograms, and genetic data to find clues about why some women later develop breast cancer. The goal is to improve risk prediction and tailor future screening and prevention strategies.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this study could improve how doctors predict breast cancer risk in women with benign breast disease, leading to earlier detection and personalized screening.
What could go wrong
This is an observational study, not a treatment trial. It may not directly change patient care, and results may take years to apply in practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BENIGN BREAST DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • Mayo Clinic in Florida

    RECRUITING

    Jacksonville, Florida, 32224-9980, United States

    Contact Email: •••••@•••••

  • Mayo Clinic in Rochester

    RECRUITING

    Rochester, Minnesota, 55905, United States

    Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.